Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delta MELD as a Predictor of Decreased Survival in High MELD Liver Transplant Recipients

NCT07570901 is registered in ClinicalTrials.gov with University of Jena as lead sponsor.

NCT NCT07570901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07570901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delta MELD as a Predictor of Decreased Survival in High MELD Liver Transplant Recipients
Lead sponsor
University of Jena
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
December 31, 2025
Enrollment
446 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

liver disease (alcoholic or not), liver transplantation